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Experimental allergic encephalomyelitis (EAE) 1 has been widely studied as a pos- 
sible experimental model for human  demyelinative diseases, the  two most common 
of which are multiple sclerosis and acute disseminated encephalomyelitis. EAE is also 
the only experimental autoimmune disease for which the exact amino acid sequence 
of an inciting molecule, basic protein of myelin, is known (1). Nearly identical basic 
proteins are found  in all mammalian myelin studied and  an encephalitogenic non- 
apeptide fragment of the bovine basic protein, which has been both isolated and syn- 
thesized de novo, has been shown  to be encephalitogenic on a  molar basis at least 
equivalent to the 170 amino acid basic protein (2). Thus,  EAE also provides an at- 
tractive model for studying the immunological mechanisms of autoimmune diseases 
in general. In view of the rapidly accumulating evidence of genetic control of immune 
responses by genes linked to the major histocompatibility locus of the species (3), it is 
now  appropriate to  determine whether  autoimmunity might  also be influenced by 
specific histocompatibility-linked immune response genes. Two  independent groups 
have observed a significant correlation between certain HL-A specificities  and presence 
of multiple sclerosis (4) .~ Susceptibility  to experimental autoimmune rnurine thyroiditis 
was recently shown to be genetically linked to the H-2 locus (5). Since EAE is both a 
possible model for multiple sclerosis and a prototype experimental autoimmune disease 
in several species, we are currently studying its genetic control. Data presented here 
show that susceptibility to the induction of histologically  determined EAE by injection 
of  purified guinea pig basic protein is determined by  a  gene,  designated Ir-EAE, 
linked to the major histocompatibility locus in the rat. 
Materials and Methods 
Rats.--Lewis/Mai  (L), Brown  Norway  (BN),  and LBNF1  hybrids were  obtained from 
Microbiological Associates, Inc., Bethesda, Md. All backcross  animals were bred in our an- 
* Supported by Research  grants  AI-09920 and  7RO1 NS  11231-01 from  the National 
Institutes of Health and Institutional support from the VA Hospital Boston,  Mass. 
:~ Portions of this work were done when R. M. W. was supported by  training grant AI- 
00426 from the National Institutes of Health and during the tenure of an Insurance Medical 
Scientist Scholarship Fund scholarship sponsored by the Massachusetts Mutual Life Insurance 
Company of Springfield. 
1  Abbreviations used in this paper: BN, Brown Norway; CFA, complete Freund's adjuvant; 
EAE, experimental allergic encephalomyelitis;  L, Lewis/Mai. 
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imal facilities,  using  rats  from  Microbiological Associates as  parents.  Eight  Lewis/Wistar 
rats obtained from Charles River Laboratories, Wilmington, Mass., were also used. Approxi- 
mately equal numbers of males and females were studied at 4-6-mo of age. The average weight 
of all BN  backcross animals was 285  4-  67  g  (SD)  including males and females together. 
Among littermates, males weighed more. 
Determination  of H-1 Phenotype.--The H-1 designation of the major histocompatibility  locus 
of the rat has been used in our figures. It is presumed to be equivalent to the AgB designation 
(see ref.  6).  The H-1 phenotype of the 42 BN backcross rats was determined on peripheral 
blood cells  by an  adaptation  of  the absorption method described by  David  and  Shreffier 
(7). 
The phenotype of Lewis backcross animals was determined by standard Trypan blue cyto- 
toxicity assay and confirmed by mixed lymphocyte reactivity with LBNF1, Lewis,  and BN 
lymph node cells by a method described in detail elsewhere (8, 9). Both these methods were 
used because the titer of our Lewis anti-BN serum was low. 
Production  of EA E.--Rats were immunized in one hind footpad with 0.1 ml of an emulsion 
containing 10 #g of guinea pig basic protein pius 100 #g H37RV Mycobacteria  tuberculosis. This 
complete Freund's adjuvant  (CFA)  emulsion was prepared in  Difco incomplete  adjuvant 
(Difco Laboratories, Detroit, Mich.) and tested for surface tension on distilled water immedi- 
ately before injection. The purified basic proteins and M. tuberculosis were the generous gift 
of Dr. Marion Kies. Animals were observed daily for clinical signs of neurological dysfunction. 
Histological Determination  of EAE.--At  the time of sacrifice  brains and spinal cords were 
removed by gross dissection and fixed for 4 days in 10% buffered formalin. Care was taken to 
obtain the cord to its most distal extent. Specimens were then washed, dehydrated through 
graded alcohol,  and embedded in paraffin. Sections were cut at six micra and stained with 
hematoxylin and eosin. Assorted sections were stained with LFB-cresyl violet for myelin and 
Bodian for axis cylinders to ensure that  the lesions  noted were in fact demyelinative. All 
sections were evaluated single blind and ranked on a scale of 0-4+. Animals designated nega- 
tive did not have a single perivacular mononuclear infiltrative or demyelinative lesion. Results 
are reported here as positive or negative. 
Skin  Tests.--Separate  animals injected for production of EAE or with CFA alone were 
skin tested at day 13 with 10 #g guinea pig basic protein and 10 #g rat S basic protein in 0.1 
ml saline. Reactions were evaluated at 4 and 24 h, and selected sights were biopsied and evalu- 
ated histologically for the presence of perivascular mononuclear cell infiltration with or without 
the presence of  significant numbers of polymorphonuclear leukocytes. Biopsies designated 
positive at 24 h  had definite evidence of mononuclear cell infiltration without a  significant 
polymorphonuclear cell component. These positive lesions  were compared in a  single blind 
fashion with skin test sites from normal animals and animals immunized with CFA alone. 
RESULTS 
All injected Lewis, LBNF,,  and Lewis backcross animals had histological 
evidence of EAE. Among the BN backcross animals studied, 25 were determined 
to have inherited the H-I  ~ allele from the LBNFI parent, and 21 of these had 
histological evidence of EAE (Table I). Among the 17 BN backcross animals 
which were tissue typed as It-in/It-1 ~, not a single lesion was detected  by the 
examiner, who was unaware of the tissue type or even whether the animal repre- 
sented  had  been  immunized.  Not  a  single  BN  animal  had  histological  signs 
of EAE. 
Among injected animals all Lewis,  14/17 LBNF1,6/9  Lewis backcross, and 
12/42  BN backcross animals showed clinical evidence of EAE. The first neuro- R.  MICHAEL  WILLIAMS  AND  MICHAEL  J.  MOORE  777 
TABLE I 
Incidence of Histological and  Clinical Signs  of EAE in  Lewis, BN,  (Lewis X  BN)F1, and 
Reciprocal Backcross Rats Immunized with 10 Izg Guinea Pig Basic Protein in 
CFA Containing 100 Izg of H~TRV M. tuberculosis 
Rat strain  H-I genotype:~ 
Signs of EAE* 
Histological  Clinical 
Lewis§  H-11/H-1 a  20/20  20/20 
BN  H-I"/H-I"  0/16  0/16 
(Lewis X BN)F1  H-11/H-1 '*  17/17  14/17 
BN backcross¶  H-11/H-1"  21/25  12/25 
H-I'*/H-I"  0/17  0/17 
Lewis backcross  H-11/H-P'  5/5  2/5 
H-11/1-1-11  4/4  4/4 
* 10 BN, 9 (Lewis X BN)FI, and all Lewis backcross animals were sacrificed at day 14. 
Others were sacrificed at day 21, although all clinically positive animals had definite paralysis 
on day 14. Two Lewis, one FI, and four BN backcross animals with severe paralysis died 
before the day of sacrifice. 
:~ For the backcross rats,  H-1 genotype was inferred from H-1 phenotype  as described in 
the text. 
§ Data from 8 Lewis/Wistar and 12 Lewis/Mal. 
¶ Included  offspring of F1 female X  BN male and reciprocal matings.  Lewis backcross 
animals were littermate  offspring from a single F1 mother. 
logical sign was a decreased tendency of the tail  to curl around the examiner's 
finger,  followed  sequentially  by  a  limp  tip  of the  tail.  The  signs  progressed 
proximally with decreasing tone in the distal portions of the tail to a completely 
flaccid tail.  Signs which followed progressively were a  waddling gait,  hind leg 
paralysis,  incontinence,  and  death  in  the  most  severely  affected  animals. 
Weight loss occurred throughout this period and may have been the first indica- 
tion of disease in affected rats (Fig. 1). The disease reached its maximum extent 
usually between days 12 and l0 and, if death or sacrific did not ensue, was mono- 
phasic with nearly complete clinical recovery in most rats. Lewis rats were the 
first  to manifest  clinical  signs and were the most severely paralyzed.  LBNF1 
animals showed clinical signs 1 or 2 days after the Lewis rats and in most cases 
the paralysis was less severe.  Clinically affected Lewis and BN backcross ani- 
mals had varying degrees of paralysis including some which were as severely 
affected as Lewis rats and others with less clinical disease than the least severely 
affected LBNF1 animals.  All of the  BN backcross animals  with  clinical  signs 
were H-P/H-P' by tissue typing. Not a single BN or H-ln/H-1 '~ BN backcross 
animal had clinical signs of EAE. 
The injected BN backcross animals were weighed repeatedly after immuniza- 
tion.  Data in Fig.  1 indicate  that the clinically affected animals  could be dis- 
tinguished from the others by a  drop in total body weight occurring as early 
as day 12  after injection.  By day 14 these differences were highly significant. 778  GENETIC CONTROL OF  EAE 
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FxG.  1.  Body weights of 42 BN backcross animals injected with  10/zg guinea pig basic 
protein in CFA containing 100 ~g H37RV M.  tuberculosis.  Solid circles: H-I"/H-I"  animals 
(none had  EAE); solid triangles: H-I~/H-1 '~ rats with no signs of EAE; half  solid circles: 
H-I~/It-1" rats with histological but no clinical signs of EAE; half solid squares: H-1Z/H-1 '~ 
animals with both clinical and histological signs of EAE. P values are presented to the nearest 
0.0001 or the first decimal greater than zero. 
However, it was not possible to differentiate histologically EAE positive but 
clinically negative H-11/It-1 ~ from unaffected It-in/It-1  "~ backcross animals on 
the basis of weight. The four histologically EAE negative 11-11/11-1 ~ BN back- 
cross animals did not lose weight. 
Skin tests of a  separate group of Lewis, BN,  and LBNF1 animals injected 
with the same guinea pig basic protein in CFA revealed that rats of all genotypes 
could manifest both Arthus and delayed type hypersensitivity to the immuniz- R.  MICHAEL WILLIAMS AND  MICHAEL J.  MOORE  779 
ing antigen and to rat S basic protein at day 13 (Table II). The two Lewis rats 
which failed to respond were severely paralyzed and emaciated at the time of 
skin  testing.  By clinical  evaluation,  skin  tests  had  minimal  erythema with 
4-8 mm induration graded +  or +  +  on a 4-[- scale. Histological evaluation of 
selected 24 h  skin  test sites showed definite lesions characteristic of delayed 
hypersensitivity when either guinea pig  or rat  S  basic protein was  the  test 
antigen  (Table III).  Positive delayed reactions were significantly less  intense 
in BN compared to Lewis rats and this observation was confirmed by histology 
as described in Table III.  The BN animals'  reactions to rat  S basic protein 
TABLE  II 
Skin  Test Reactivity  of Lewis, BN, and  (Lewis  X  BN)F1 Rats Immunized with 10 I~g Guinea 
Pig Basic Protein  in CFA Containing  100 #g of H37RV M. tuberculosis 
Rat Strain 
4 h (Arthus) reaction  24 h (delayed) reaction 
Guinea pig basic  Rat S basic  Guinea  pig basic  Rat S basic 
protein  protein  protein  protein 
Lewis  3/5*  3/5  3/5  1/5 
BN  5/5  5/5  8/8  8/8 
(Lewis  X  BN)F1  5/5  5/5  5/5  4/5 
* No. positive/no, tested. All animals were tested on day  13  after injection. The Lewis 
animals had severe clinical signs of EAE, Ft animals showed mild but definite paralysis, and 
the BN animals had no clinical signs of EAE. The skin test dose was 10 #g in saline. 
TABLE  III 
Histological Evaluation  of 24 h Skin Reactions in Rats Immunized with 10 #g Guinea Pig Basic 
Protein  in CFA Containing  100 #g H37RV M. tuberculosis* 
Rat strain 
Skin test antigen 
Guinea pig basic protein  Rat S basic  protein 
Lewis  +++~1(  +++ 
Lewis  + +  +  + +  + 
BN  +++  ++)11( 
B N  +  +  Trace 
BN  ++~1(  Trace 
BN  + + )1(  Trace 
BN  Negative  Trace 
BN (unimmunized)  Negative  Negative 
BN (immunized with CFA alone)  Negative  Negative 
(Lewis  X  BN)F1  +  ++ 
(Lewis  X  BN)F1  Negative  ++ 
* These represent biopsies from selected animals described in Table II. All specimens  were 
coded and histological evaluation was done by M.J.M. without prior knowledge of the rat 
strain or test antigen. "Trace" indicates definite evidence of perivascular mononuclear cells, 
while +,  ++,  and  +-t-+  indicate "mild", "moderate", and "marked" evidence of peri- 
vascular mononuclear cells. Lesions marked (~10 also had evidence of polymorphonuclear cell 
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were very weak,  but were definitely scored positive by single blind examina- 
tion of the sections. Normal animals or those immunized with CFA alone were 
skin test negative to both antigens by all criteria. 
DISCUSSION 
The findings that  all Lewis, LBNF1, Lewis backcross, and one half of BN 
backcross animals  were susceptible  to the induction of histologically verified 
EAE indicate that susceptibility was  determined by an  autosomal  dominant 
gene.  The fact  that  21/25  BN  backcross  animals  which  inherited  the  H-11 
allele from the LBNFI parent were EAE+ while 0/17 H-I~/H-1  n BN backcross 
rats were EAE+, strongly indicates that susceptibility is linked to the major 
histocompatibility locus of the rat  (H-1 or AgB). Thus, induction of EAE by 
injection oI purified guinea pig basic protein  in  the  rat  satisfies  the  genetic 
predictions made from the hypothesis that susceptibility depends on an H-I- 
linked  immune  response  gene,  designated  Ir-EAE,  which  determines  cell- 
mediated  reactivity  to  an  encephalitogenic  component  of  guinea  pig  basic 
protein. Lewis animals are designated Ir-EAE+  and BN animals Ir-EAE-. 
The existence of 4/25 H-I~/H-1  n injected BN backcross animals which did 
not manifest EAE remains to be explained. These could represent examples of 
recombination between the Ir-EAE gene(s)  and gene(s)  determining serolog- 
ically defined histocompatibility antigens,  a  situation  analogous  to  some Ir 
genes in guinea pigs and mice (10). However, no reciprocal recombinants, i.e. 
H-I'~/H-1  n Ir-EAE+,  individuals  were  observed.  Thus,  the  possibility  that 
the Ir-EAE gene was inherited but not expressed by some BN backcross in- 
dividuals remains open. 
Clinical signs  of EAE were present in only 12 of the 21 histologically EAE 
positive or in  12 of 25 H-ll/H-1  ~ BN backcross animals. This observation is 
mathematically  consistent  with  the  possibility  that  there  is  a  second inde- 
pendently segregating gene for susceptibility to clinically defined EAE. How- 
ever, 3/17 LBNF1 animals were free of clinical signs even though  17/17 had 
histological evidence of EAE.  Therefore, it is more likely that  there exists a 
threshold for expression of clinical  signs  when  the  histologically determined 
EAE is present. We have never observed an injected animal which manifested 
clinical signs of paralysis without also showing histological evidence Of EAE. 
Immune response genes control cell-mediated reactions with exquisite anti- 
genic specificity, and  the  mechanism  of gene  action  may include  control of 
antigen recognition at the T cell level (10). The fact that susceptibility to EAE 
lesions was H-1 linked must be considered in terms of the observations that, as 
compared to Ir-EAE-- BN rats, Lewis rats develop stronger delayed skin reac- 
tions, have higher levels of T  lymphocyte DNA synthesis in culture, and are 
Ir-EAE+. These considerations could be interpreted to support the possibility 
that development of EAE lesions is the first known example of quantitative ex- 
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indicate that  the nonspecific differences observed between Lewis  and BN T 
lymphocyte reactivity in culture are not genetically linked to the major histo- 
compatibility locus (9,  11). Therefore, in our opinion the Ir-EAE gene is more 
likely  to  determine  reactivity at  the  level  of  antigen  specificity,  while  the 
quantitative expression of this reaction may be influenced by other genes in- 
cluding some which may control thymus-derived cell function. Thus, the precise 
antigenic specificity of the Ir-EAE gene was evaluated with the basic protein 
preparations available when these experiments were carried out. 
Both Ir-EAE+  Lewis  and LBNF1 rats  and Ir-EAE--  BN  rats  were im- 
munized with purified guinea pig basic protein and skin  tested  with the ho- 
mologous antigen and with purified rat S basic protein. Rat S basic protein is 
the  smaller  of  the  two  basic  proteins  which  occur in  rat  myelin.  It  differs 
from the larger protein in that it lacks approximately 40 amino acids in the 
carboxy-terminal region after  tryptophane  (12).  This  deletion  contains none 
of  the rat  basic protein encephalitogenic site  as  tested  in  rats  but  does  in- 
clude part  of  the  active site for guinea  pigs.  Animals of each genotype had 
Arthus and delayed skin reactivity to both antigens.  The delayed reactions of 
the Ir-EAE--  BN rats were less intense than those of Lewis and LBNF1 rats, a 
result consistent with the antigen  independent differences in  thymus-derived 
cell function between the two strains  (9,  11,  13).  The fact that  BN rats im- 
munized with guinea pig basic protein were definitely positive when tested for 
delayed hypersensitivity with  rat  S  basic  protein as well as  the homologous 
antigen rules out the possibility that the Ir-EAE gene only controls specific reac- 
tivity to the whole guinea pig basic protein molecule or even to those portions 
which cross react with the rat S basic protein. The precise antigenic specificity 
of the Ir-EAE gene remains to be determined by direct studies utilizing peptides 
of defined amino acid sequence. 
Recent data of Gasser et a12 clearly demonstrate AgB-linked susceptibhty to 
EAE induction in these rat strains after injection of guinea pig spinal cord in 
CFA. These data are entirely analogous to ours including some EAE negative 
BN backcross individuals which inherited the major histocompatibility locus 
of the Lewis strain, but no EAE positive BN backcross individuals which did 
not inherit this allele.  Thus, even when immunized with such a complex anti- 
genic mixture as whole spinal cord, the susceptibility to EAE induction behaves 
according to predictions based on a  single Ir-gene linked to the major histo- 
compatibility locus. The possible existence of Ir-EAE  genes in other species 
would  also  offer some explanation for nonuniform reactivity among outbred 
animals tested with various basic protein fraganents (14). The extent to which 
EAE is a model for human demyelinating diseases  such as multiple sclerosis 
would  be strengthened if the  correlation of susceptibility and  certain HL-A 
specificities reflects Ir gene participation in the human disease. 
3 Newlin, C. M., personal communication. 782  GENET~  CONTROL OF EAE 
SUMMARY 
Experimental allergic encephalomyelitis (EAE) was induced in rats of various 
genotypes by injection of 10/~g guinea pig basic protein in complete Freund's 
adjuvant  containing  100  #g  H,7  RV  M.  tuberculosis.  Histologically verified 
EAE was present in 20/20 Lewis, 17/17 (Lewis)< BN)F1,9/9 Lewis backcross, 
and 21/42  BN backcross rats. Among the BN backcross animals,  25/42  were 
determined  to  carry  the  major histocompatibility  type  characteristic  of  the 
Lewis strain and 21 of these had EAE. Separate groups of Lewis, BN, and (Lewis 
)<  BN)F1 rats were immunized as described  and  skin tested on day 13  with 
10 #g guinea pig basic protein and rat S basic protein. Animals of each genotype 
had Arthus and delayed skin reactivity to both antigens. These data are com- 
patible with the hypothesis that susceptibility to EAE in rats is controlled by 
an autosomal dominant gene linked to the major histocompatibility locus. It is 
proposed that this is an immune response gene, designated Ir-EAE, which con- 
trols T  cell reactivity directed against a highly encepha]itogenic portion of the 
basic protein molecule. 
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